CSIMarket
 
Ibio inc   (IBIO)
Other Ticker:  
 
 

Ibio Inc Growth Comparisons

Select each growth Category to receive further Information



IBIO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) - -4.74 % - -0.55 %
Q / Q Revenue Growth (Q3 MRQ) - -0.76 % - -1.18 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) - -5.42 % - %
Seq. Revenue Growth (for 12 months ending Q3 TTM) - -1.27 % - 0.08 %
Revenue 5 Year Average Growth - 6.79 % 7.31 % 8.34 %


IBIO's Growth Comparisons in I. Quarter 2023




Ibio Inc reported top-line of $ 0 millions in the first quarter 2023, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry fell by -4.74%, while the top-line in the Healthcare sector decreased by %, and overall market declined by -0.55% from the first quarter 2022.

Sequentially company's Revenue were unchanged from the forth quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the first quarter 2023 earnings reports, average yearly sales growth is 8.34%.


Growth Rates of IBIO's Income in the first quarter 2023


IBIO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - -48.29 % -41.68 % 0.59 %
Seq. Operating Income Change (Q3 MRQ) - 40.17 % 37.14 % 7.23 %
Y / Y Operating Income Growth (Q3 TTM) - -26.2 % -26.59 % -9.01 %
Seq. Operating Income Growth (Q3 TTM) - -14.99 % -12.38 % -0.23 %
Operating Income 5 Year Avg. Change - 4.16 % -0.61 % 7.72 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - -68.78 % -77.97 % 1.83 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 76.58 % 384.2 % 10.6 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - -60.94 % -56.82 % -8.43 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - -33.81 % -32.2 % 0.4 %
Income from Cont. Ops. 5 Year Avg. Change - 0.23 % -4.6 % 7.55 %

IBIO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 23.68 % 7.04 % 7.49 %
Q / Q Net Income Growth (Q3 MRQ) - 641.99 % 2333.8 % 14.75 %
Y / Y Net Income Change (Q3 TTM) - -33.18 % -32.49 % -6.17 %
Seq. Net Income Change (Q3 TTM) - 11.16 % 3.48 % 1.93 %
Net Income 5 Year Avg. Growth - 6.6 % 0.51 % 7.78 %

IBIO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - -60.89 % -77.97 % 1.83 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 71.87 % 384.2 % 10.6 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - 117.26 %
EPS from Cont. Ops. 5 Year Avg. Growth - -7.95 % -4.6 % 7.55 %



IBIO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - 54.96 % 7.04 % 7.55 %
Q / Q EPS Net Growth (Q3 MRQ) - 622.17 % 2333.8 % 14.75 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 60498.58 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - 115.79 %
EPS Net 5 Year Avg. Change - 6.6 % 0.51 % 7.78 %



Ibio Inc reported bottom-line of $ -4.80 in the first quarter, compare to $ -41.00 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 54.96%, while Healthcare sector increased by 7.04%, and overall market improved by 7.49%.

Sequentially company's EPS were unchanged from the forth quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the first quarter 2023 financial results, average yearly income per share growth is 7.78%.

IBIO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 11.75 % 4.9 % 25.82 %
Seq. Free Cash Flow Change (Q3 MRQ) - 112.04 % 51.72 % 28.6 %
Y / Y Free Cash Flow Change (Q3 TTM) - -9.5 % -8.46 % -3.04 %
Seq. Free Cash Flow Change (Q3 TTM) - 3.94 % 2.41 % 11.75 %
Free Cash Flow 5 Year Avg. Change - 13.56 % 9.27 % 9.83 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 43.11 % 8.44 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - 17.06 % -
Net Cash Flow 5 Year Avg. Change - -0.29 % 4.38 % 26.69 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - 1.13 % 3.34 % 69 %
Seq. Capital Expenditures Change (Q3 MRQ) - 5.79 % 5.51 % 16.39 %
Y / Y Capital Expenditures Change (Q3 TTM) -75.48 % 8.65 % 5.42 % -8.14 %
Seq. Capital Expenditures Change (Q3 TTM) -41.74 % -0.19 % 0.77 % 18.42 %
Capital Expenditures 5 Year Avg. Change 39.68 % 10.35 % 7.82 % 7.36 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com